Brief: Nordic Nanovector ASA Says merger with APIM is in best interests of shareholders

Thor Medical ASA

21/11/2022 09:38

Nov 21 (Reuters) - Nordic Nanovector ASA  NANOVN.OL :
    * SAYS STRATEGIC REVIEW TO EXPLORE COMPANY'S OPTIONS HAS
CONCLUDED
THAT A STAND-ALONE STRATEGY IS NOT A VIABLE OPTION
    * DISCUSSIONS WITH SEVERAL PLAYERS DID NOT RESULT IN TERMS
THAT
WERE COMPETITIVE OR THAT RECOGNISED APPROPRIATE VALUATION OF CO

Source text for Eikon:  ID:nPn3KzkvDa 
Further company coverage:  NANOVN.OL 
 ((Reuters.Briefs@thomsonreuters.com;))